Neill A. Giese

5.6k total citations · 3 hit papers
43 papers, 4.5k citations indexed

About

Neill A. Giese is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Neill A. Giese has authored 43 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 21 papers in Hematology and 13 papers in Genetics. Recurrent topics in Neill A. Giese's work include Chronic Myeloid Leukemia Treatments (12 papers), PI3K/AKT/mTOR signaling in cancer (12 papers) and Chronic Lymphocytic Leukemia Research (11 papers). Neill A. Giese is often cited by papers focused on Chronic Myeloid Leukemia Treatments (12 papers), PI3K/AKT/mTOR signaling in cancer (12 papers) and Chronic Lymphocytic Leukemia Research (11 papers). Neill A. Giese collaborates with scholars based in United States, Japan and Sweden. Neill A. Giese's co-authors include Xiaohong Lin, Akiko Nishiyama, William B. Stallcup, Carl‐Henrik Heldin, Nathalie A. Lokker, Brian J. Lannutti, Carol M. Sullivan, Stanley J. Hollenbach, Sarah Meadows and Kamal D. Puri and has published in prestigious journals such as Science, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Neill A. Giese

43 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability

2010 588 citations Brian J. Lannutti, Sarah Meadows et al. Blood profile →
Co-localization of NG2 proteoglycan and PDGF ?-receptor on O2A progenitor cells in the developing rat brain

1996 554 citations Akiko Nishiyama, Xiaohong Lin et al. Journal of Neuroscience Research profile →
The phosphoinositide 3′-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia

2011 442 citations Julia Hoellenriegel, Sarah Meadows et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Neill A. Giese United States	26	2.2k	1.8k	1.0k	920	741	43	4.5k
Alan H. Shih United States	25	2.7k 1.2×	800 0.5×	995 1.0×	128 0.1×	443 0.6×	37	3.8k
Meena Gujrati United States	35	1.5k 0.7×	685 0.4×	226 0.2×	323 0.4×	220 0.3×	87	3.0k
C. Glenn Begley Australia	33	2.0k 0.9×	610 0.3×	1.9k 1.9×	143 0.2×	1.0k 1.4×	73	4.5k
Ralf Lesche Germany	31	3.9k 1.8×	296 0.2×	157 0.2×	504 0.5×	406 0.5×	63	5.1k
Francesca Carlomagno Italy	42	2.9k 1.3×	358 0.2×	309 0.3×	776 0.8×	311 0.4×	92	6.2k
N. Shaun B. Thomas United Kingdom	30	1.9k 0.9×	326 0.2×	449 0.4×	275 0.3×	778 1.0×	56	3.1k
Johan Lennartsson Sweden	31	1.8k 0.8×	367 0.2×	388 0.4×	249 0.3×	880 1.2×	76	3.5k
Antonio Daga Italy	35	2.3k 1.0×	934 0.5×	134 0.1×	108 0.1×	727 1.0×	96	4.2k
Judith Staerk Belgium	22	3.1k 1.4×	2.9k 1.7×	2.0k 2.0×	153 0.2×	329 0.4×	34	5.0k
Elizabeth H. Stover United States	16	1.2k 0.5×	422 0.2×	207 0.2×	350 0.4×	508 0.7×	46	2.7k

Countries citing papers authored by Neill A. Giese

Since Specialization

Citations

This map shows the geographic impact of Neill A. Giese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neill A. Giese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neill A. Giese more than expected).

Fields of papers citing papers by Neill A. Giese

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neill A. Giese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neill A. Giese. The network helps show where Neill A. Giese may publish in the future.

Co-authorship network of co-authors of Neill A. Giese

This figure shows the co-authorship network connecting the top 25 collaborators of Neill A. Giese. A scholar is included among the top collaborators of Neill A. Giese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neill A. Giese. Neill A. Giese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hoellenriegel, Julia, Sarah Meadows, Mariela Sivina, et al.. (2011). The phosphoinositide 3′-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia. Blood. 118(13). 3603–3612. 442 indexed citations breakdown →

Ikeda, Hiroshi, Teru Hideshima, Mariateresa Fulciniti, et al.. (2010). PI3K/p110δ is a novel therapeutic target in multiple myeloma. Blood. 116(9). 1460–1468. 156 indexed citations

Puri, Kamal D., et al.. (2009). IC87114, a Selective Inhibitor of PI3Kδ Suppresses Joint Inflammation and Bone Erosion in Collagen-Induced Arthritis in Rat (50.14). The Journal of Immunology. 182(Supplement_1). 50.14–50.14. 1 indexed citations

Hideshima, Teru, Mariateresa Fulciniti, Giulia Perrone, et al.. (2009). B037 CAL-101: A Selective Inhibitor of PI3K p110D for the Treatment of Multiple Myeloma. Clinical Lymphoma & Myeloma. 9. S98–S99. 1 indexed citations

Radomska, Hanna S., Daniela S. Daniela Sanchez Bassères, Rui Zheng, et al.. (2006). Block of C/EBPα function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations. The Journal of Experimental Medicine. 203(2). 371–381. 161 indexed citations

Heath, Julie A., Mukund M. Mehrotra, Jin‐Chen Yu, et al.. (2004). Identification of 4-piperazin-1-yl-quinazoline template based aryl and benzyl thioureas as potent, selective, and orally bioavailable inhibitors of platelet-derived growth factor (PDGF) receptor. Bioorganic & Medicinal Chemistry Letters. 14(19). 4867–4872. 12 indexed citations

Matsuno, Kenji, Takao Nakajima, Michio Ichimura, et al.. (2003). Potent and selective inhibitors of platelet-derived growth factor receptor phosphorylation. Part 4: structure–activity relationships for substituents on the quinazoline moiety of 4-[4-(N-substituted(thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline derivatives. Bioorganic & Medicinal Chemistry Letters. 13(18). 3001–3004. 11 indexed citations

Kozaki, Koichi, Wolfgang E. Kaminski, Jingjing Tang, et al.. (2002). Blockade of Platelet-Derived Growth Factor or Its Receptors Transiently Delays but Does Not Prevent Fibrous Cap Formation in ApoE Null Mice. American Journal Of Pathology. 161(4). 1395–1407. 64 indexed citations

Kelly, Louise, Jin‐Chen Yu, Christina Boulton, et al.. (2002). CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML). Cancer Cell. 1(5). 421–432. 240 indexed citations

10.

Matsuno, Kenji, Takao Nakajima, Michio Ichimura, et al.. (2002). Potent and Selective Inhibitors of PDGF Receptor Phosphorylation. 2. Synthesis, Structure Activity Relationship, Improvement of Aqueous Solubility, and Biological Effects of 4-[4-(N-Substituted (thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline Derivatives. Journal of Medicinal Chemistry. 45(20). 4513–4523. 14 indexed citations

11.

Pandey, Anjali, Deborah L. Volkots, Jack W. Rose, et al.. (2002). Identification of Orally Active, Potent, and Selective 4-Piperazinylquinazolines as Antagonists of the Platelet-Derived Growth Factor Receptor Tyrosine Kinase Family. Journal of Medicinal Chemistry. 45(17). 3772–3793. 92 indexed citations

12.

LaRochelle, William J., Michael Jeffers, William F. McDonald, et al.. (2001). PDGF-D, a new protease-activated growth factor. Nature Cell Biology. 3(5). 517–521. 300 indexed citations

13.

Yu, Jin‐Chen, Nathalie A. Lokker, Stanley J. Hollenbach, et al.. (2001). Efficacy of the Novel Selective Platelet-Derived Growth Factor Receptor Antagonist CT52923 on Cellular Proliferation, Migration, and Suppression of Neointima following Vascular Injury. Journal of Pharmacology and Experimental Therapeutics. 298(3). 1172–1178. 34 indexed citations

14.

Toki, Shinichiro, Tsutomu Agatsuma, Keiko Ochiai, et al.. (2001). RP-1776, a Novel Cyclic Peptide Produced by Streptomyces sp., Inhibits the Binding of PDGF to the Extracellular Domain of Its Receptor.. The Journal of Antibiotics. 54(5). 405–414. 45 indexed citations

15.

Toki, Shinichiro, Takeo Tanaka, Youichi Uosaki, et al.. (1999). RP-1551s, a Family of Azaphilones Produced by Penicillium sp., Inhibit the Binding of PDGF to the Extracellular Domain of Its Receptor.. The Journal of Antibiotics. 52(3). 235–244. 21 indexed citations

16.

Giese, Neill A., Monique M.H. Marijianowski, Oscar McCook, et al.. (1999). The Role of Alpha and Beta Platelet-Derived Growth Factor Receptor in the Vascular Response to Injury in Nonhuman Primates. Arteriosclerosis Thrombosis and Vascular Biology. 19(4). 900–909. 68 indexed citations

17.

Lokker, Nathalie A., JAMES P. OʼHARE, James Tomlinson, et al.. (1997). Functional Importance of Platelet-derived Growth Factor (PDGF) Receptor Extracellular Immunoglobulin-like Domains. Journal of Biological Chemistry. 272(52). 33037–33044. 46 indexed citations

18.

Nishiyama, Akiko, Xiaohong Lin, Neill A. Giese, Carl‐Henrik Heldin, & William B. Stallcup. (1996). Interaction between NG2 proteoglycan and PDGF ?-receptor on O2A progenitor cells is required for optimal response to PDGF. Journal of Neuroscience Research. 43(3). 315–330. 202 indexed citations

19.

Nishiyama, Akiko, Xiaohong Lin, Neill A. Giese, Carl‐Henrik Heldin, & William B. Stallcup. (1996). Co-localization of NG2 proteoglycan and PDGF ?-receptor on O2A progenitor cells in the developing rat brain. Journal of Neuroscience Research. 43(3). 299–314. 554 indexed citations breakdown →

20.

Giese, Neill A., et al.. (1991). Variant PDGF Ligands and Receptors---Structure-function Relationship. Physiology. 6(2). 56–60. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact